arrow
Back
R

Richard Bevan-Thomas

Affiliation pending

6H-index
25Paper Count
420Citation Count
Published Papers 7
Publication Date
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients
err2025-09-22
err0
errOAAI
errNeal D. Shore; Christopher M. Pieczonka; Sean Heron; Mukaram Gazi; David J. Cahn; Laurence H. Belkoff; Aaron D. Berger; Brian Mazzarella; Joseph Veys; David Morris; Richard Bevan-Thomas; Alexander Engelman; Paul Dato; David R. Wise; Mary Kay Hardwick; Kerry W. Aradhya; Brandie Heald; Robert L. Nussbaum; Kathryn E. Hatchell; Brianna Bucknor; Edward D. Esplin; Sarah M. Nielsen
errShare
errSave
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
err2024-12-01
err3
PREAI
errShore, Neal; Pieczonka, Christopher; Heron, Sean; Gazi, Mukaram; Cahn, David; Belkoff, Laurence H.; Berger, Aaron; Mazzarella, Brian; Veys, Joseph; Idom, Charles; Morris, David; Jayram, Gautam; Engelman, Alexander; Dato, Paul; Bevan-Thomas, Richard; Wise, David R.; Hardwick, Mary Kay; Rojahn, Susan; Layman, Paige; Heald, Brandie; Ellsworth, Rachel E.; Hatchell, Kathryn E.; Nussbaum, Robert L.; Nielsen, Sarah M.; Esplin, Edward D.
errShare
errSave
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial
err2023-10-01
err8
errOAAI
errShore, Neal; Gazi, Mukaram; Pieczonka, Christopher; Heron, Sean; Modh, Rishi; Cahn, David; Belkoff, Laurence H.; Berger, Aaron; Mazzarella, Brian; Veys, Joseph; Idom, Charles; Morris, David; Jayram, Gautam; Engelman, Alexander; Bukkapatnam, Raviender; Dato, Paul; Bevan-Thomas, Richard; Cornell, Robert; Wise, David R.; Hardwick, Mary Kay; Hernandez, Ryan D.; Rojahn, Susan; Layman, Paige; Hatchell, Kathryn E.; Heald, Brandie; Nussbaum, Robert L.; Nielsen, Sarah M.; Esplin, Edward D.
errShare
errSave
Universal germline testing of prostate cancer patients: Are genetic testing guidelines an aid or an impediment to precision therapy?
err2021-09-01
err0
errOAAI
errHardwick, M. K.; Esplin, E.; Mazzerelli, B.; Morris, D.; Heron, S.; Veys, J.; Engelman, A.; Dato, P.; Bevan-Thomas, R.; Wise, D.; Cornell, R.; Berger, A.; Nielsen, S.; Hatchell, K.; Nussbaum, R.; Gazi, M.; Pieczonka, C. M.; Belkoff, L.; Cahn, D. J.; Shore, N. D.
errShare
errSave
EFFICACY OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) AS A PRIMARY MONOTHERAPY FOR LOW RISK LOCALIZED PROSTATE CANCER: OUTCOMES FROM THE ENLIGHT TRIAL
err2016-04-01
err0
errOAAI
errRobertson, Cary; Sliwinski, Anthony; Wallen, Eric; Ward, John; Orovan, William; Locke, Donald; Crawford, E. David; Maroni, Paul; Donnell, Robert; Grunberger, Ivan; Colon, Ivan; Bevan-Thomas, Richard; Munver, Ravi; Sawczuk, Ihor; Chang, Sam; Gill, Inderbir
errShare
errSave
errShare
errSave